| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.18B | 38.48B | 36.38B | 35.55B | 33.87B | 31.32B |
| Gross Profit | 9.19B | 8.88B | 8.49B | 8.47B | 8.18B | 7.41B |
| EBITDA | 5.00B | 4.78B | 4.58B | 4.44B | 4.32B | 3.62B |
| Net Income | 3.38B | 3.21B | 3.05B | 2.92B | 2.79B | 2.28B |
Balance Sheet | ||||||
| Total Assets | 49.98B | 52.06B | 50.84B | 48.19B | 46.85B | 44.31B |
| Cash, Cash Equivalents and Short-Term Investments | 23.71B | 24.30B | 27.13B | 24.04B | 24.20B | 21.53B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.72B | 8.59B | 8.98B | 8.41B | 8.73B | 8.12B |
| Stockholders Equity | 43.26B | 43.47B | 41.86B | 39.78B | 38.12B | 36.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.40B | 4.59B | 2.91B | 2.77B | 2.13B |
| Operating Cash Flow | 0.00 | 1.57B | 4.71B | 2.95B | 2.93B | 2.24B |
| Investing Cash Flow | 0.00 | -3.09B | -1.14B | -1.34B | -57.84M | 342.11M |
| Financing Cash Flow | 0.00 | -1.61B | -983.76M | -1.26B | -703.42M | -983.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥47.94B | 12.84 | 8.02% | 2.73% | 8.26% | 9.09% | |
77 Outperform | ¥71.98B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
74 Outperform | ¥95.21B | 11.45 | ― | 2.59% | 5.22% | -6.62% | |
74 Outperform | ¥64.44B | 13.29 | ― | 2.41% | 13.05% | 4.42% | |
70 Outperform | ¥90.70B | 18.51 | ― | 1.02% | 26.47% | 142.77% | |
63 Neutral | ¥101.29B | 56.92 | ― | 0.72% | 22.13% | 254.87% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |